PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics

Pharmacogenet Genomics. 2014 Sep;24(9):464-76. doi: 10.1097/FPC.0000000000000058.

Authors

Ellen M McDonagh¹, Caroline F Thorn, John T Callaghan, Russ B Altman, Teri E Klein

Affiliation

¹ Departments of aGenetics bBioengineering, Stanford University, Stanford, California cACOS for Research, Department of Veterans Affairs Medical Center Departments of dMedicine ePharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Gene Expression Regulation / drug effects
Genetic Variation
Gout Suppressants / adverse effects
Gout Suppressants / pharmacology*
Humans
Uric Acid / metabolism*

Substances

Gout Suppressants
Uric Acid

Grants and funding